# A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

> **NCT06457503** · PHASE4 · RECRUITING · sponsor: **Coherus Oncology, Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Nasopharyngeal Cancer Recurrent

## Interventions

- **DRUG:** Toripalimab
- **DRUG:** Cisplatin
- **DRUG:** Gemcitabine
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT06457503
- **Lead sponsor:** Coherus Oncology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06457503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06457503, "A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06457503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*